Cat. No. | Product name | CAS No. |
DCC5584 |
Yt-146
Selective A 2A receptor agonist |
90596-75-1 |
DCC5585 |
Yu2534342249
Novel γ-lactam pyrazolidinone, targeting penicillin-binding proteins (PBPs) and incorporating a siderophore moiety to facilitate uptake into the periplasm, being effective against multidrug-resistant gram-negative Bacilli |
|
DCC5586 |
Yw2065
Novel inhibitor of Wnt signaling by stabilizing Axin-1, a scaffolding protein that regulates proteasome degradation of β-catenin |
2131223-85-1 |
DCC5587 |
Yycg Inhibitor 16
Novel YycG inhibitor, inhibiting planktonic cells of E. faecalis, including the vancomycin- or linezolid-resistant strains |
506429-34-1 |
DCC5588 |
Yycg Inhibitor 62
Novel YycG inhibitor, significantly inhibited biofilm formation in static and dynamic conditions |
|
DCC5589 |
Yz-2-90
Novel activator of JNK, binding directly to microtubules, inducing ERK-mediated mitotic arrest and subsequent apoptosis |
1159013-10-1 |
DCC5590 |
Z118332870
Novel first-in-class inhibitor of BRD4 and EGFR kinase |
1223377-83-0 |
DCC5591 |
Z1241145220
Novel potent ligand of σ2 receptor (K i =7nM) |
|
DCC5592 |
Z1913661252
Novel riboswitch activator, binding ZTP riboswitches, and activating transcription more strongly than ZMP in vitro |
1798713-75-3 |
DCC5593 |
Z4446724338
Novel potent dual σ1/2 ligand (σ1 K i =5nM, σ2 K i =3nM), showing anti-allodynic in a model of neuropathic pain |
2445793-01-9 |
DCC5594 |
Z56965384
Novel USP10 inhibitor |
438607-49-9 |
DCC5595 |
Zarilamide
Inhibitor of the nuclear division in germinating zoospore cysts of Phytophthora capsici via destruction of the microtubule cytoskeleton, and a consequent inhibition of mitosis |
84527-51-5 |
DCC5596 |
Zatosetron
Serotonin 5-HT3 receptor antagonist |
123482-22-4 |
DCC5597 |
Zbh-1205
Novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than CPT-11 and SN38 at inhibiting topoismerase-1 |
|
DCC5598 |
Zd1611
Endothelin Receptor Antagonist |
186497-38-1 |
DCC5599 |
Zd2138
Potent, orally active inhibitor of 5-lipoxygenase (5-LO) |
140841-32-3 |
DCC5600 |
Zd6126
Vascular targeting agent (VTA) |
219923-05-4 |
DCC5601 |
zd6169
Potassium channel opener |
147696-46-6 |
DCC5602 |
Zdhhc Substrate Peptide
ZDHHC (zinc finger Asp-His-His-Cys) substrate peptide, a 15-mer peptide sequence from KRas4a plus two tryptophan residues |
|
DCC5603 |
Zdlt-1
Novel potent HDAC inhibitor with IC50 values for class I HDACs 1, 2, and 3 below 4 nM, and IC50 for HDAC6 at 6 nM. |
|
DCC5604 |
Z-don-val-pro-leu-ome
Site specific inhibitor of tissue transglutaminase |
|
DCC5605 |
Zdwx-25
Novel daul inhibitor of GSK-3β (IC 50 = 71 nM) and DYRK1A (IC 50 = 103 nM) with good blood-brain barrier penetrability, inhibiting hyperphosphorylation of tau protein in okadaic acid (OKA)-induced SH-SY5Y cells |